Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 18/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 16/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3228727 | 0.90 | PTGS2 (0.46) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL6995804 | 0.90 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6993821 | 0.88 | PTGS2 (0.50) | PTGS2PTGS1CA1CA2 | |
| SCHEMBL3231323 | 0.87 | PTGS2 (0.41) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL6993214 | 0.87 | PTGS2 (0.42) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL6997219 | 0.87 | CA1 (0.41) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7001723 | 0.87 | PTGS2 (0.48) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL6993926 | 0.84 | CA1 (0.40) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7001634 | 0.84 | CA1 (0.41) | PTGS2PTGS1CA12CA1CA2 | |
| SCHEMBL7000249 | 0.83 | KDM4E (0.39) | PTGS2PTGS1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |